Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized dynamic TCM treatment versus fixed Qiming granule regimen for diabetic microvascular complications
ChiCTR-IPR-15007072Phase 4Not yet recruiting
- Sponsor
- Chengdu University of Traditional Chinese Medicine
- Start
- Jan 2014
- Countries
- 1
01
Overview
Phase 4, open-label trial of qiming granule and Elix Cycle Balance in diabetic retinopathy (DR), diabetic glomerulosclerosis and diabetic neuropathy (8 arms), sponsored by Chengdu University of Traditional Chinese Medicine. Primary endpoints: Best corrected visual acuity, Traditional Chinese medicine syndrome evaluation and 6 more. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
qiming granuleElix Cycle Balance
03
Conditions
diabetic retinopathy (DR)diabetic glomerulosclerosisdiabetic neuropathy
Beyond the preview
Go deeper on ChiCTR-IPR-15007072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007072.